Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Cohen AD, Rabinovici GD, Mathis CA, Jagust WJ, Klunk WE, Ikonomovic MD.

Adv Pharmacol. 2012;64:27-81. doi: 10.1016/B978-0-12-394816-8.00002-7. Review.

PMID:
22840744
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

In vivo human amyloid imaging.

Sojkova J, Resnick SM.

Curr Alzheimer Res. 2011 Jun;8(4):366-72. Review.

PMID:
21222593
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

PET imaging of brain amyloid in dementia: a review.

Quigley H, Colloby SJ, O'Brien JT.

Int J Geriatr Psychiatry. 2011 Oct;26(10):991-9. doi: 10.1002/gps.2640. Epub 2010 Dec 28. Review.

PMID:
21905095
[PubMed - indexed for MEDLINE]
4.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
[PubMed - indexed for MEDLINE]
5.

Molecular imaging of dementia.

Mori T, Maeda J, Shimada H, Higuchi M, Shinotoh H, Ueno S, Suhara T.

Psychogeriatrics. 2012 Jun;12(2):106-14. doi: 10.1111/j.1479-8301.2012.00409.x. Review.

PMID:
22712644
[PubMed - indexed for MEDLINE]
6.

The prognostic value of amyloid imaging.

Gelosa G, Brooks DJ.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1207-19. doi: 10.1007/s00259-012-2108-x. Epub 2012 Apr 11. Review.

PMID:
22491780
[PubMed - indexed for MEDLINE]
7.

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Rabinovici GD, Jagust WJ.

Behav Neurol. 2009;21(1):117-28. doi: 10.3233/BEN-2009-0232. Review.

PMID:
19847050
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Amyloid imaging with PET in early Alzheimer disease diagnosis.

Rowe CC, Villemagne VL.

Med Clin North Am. 2013 May;97(3):377-98. doi: 10.1016/j.mcna.2012.12.017. Review.

PMID:
23642577
[PubMed - indexed for MEDLINE]
9.

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. Review.

PMID:
22710919
[PubMed - indexed for MEDLINE]
10.

Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.

Scheinin NM, Scheinin M, Rinne JO.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):265-79. Review.

PMID:
21532540
[PubMed - indexed for MEDLINE]
11.

Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.

Chételat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of Ageing Research Group.

Neurodegener Dis. 2012;10(1-4):141-4. doi: 10.1159/000334295. Epub 2012 Feb 1. Review.

PMID:
22301812
[PubMed - indexed for MEDLINE]
12.

Alzheimer's disease: genetic basis and amyloid imaging as endophenotype.

Berti V, Nacmias B, Bagnoli S, Sorbi S.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):225-36. Review.

PMID:
21532537
[PubMed - indexed for MEDLINE]
13.

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):230-8. doi: 10.1016/j.jalz.2010.03.008. Review.

PMID:
20451871
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Amyloid imaging.

Villemagne VL, Rowe CC.

Int Psychogeriatr. 2011 Sep;23 Suppl 2:S41-9. doi: 10.1017/S1041610211000895. Review.

PMID:
21729418
[PubMed - indexed for MEDLINE]
15.

Molecular neuroimaging in Alzheimer's disease.

Matsuda H, Imabayashi E.

Neuroimaging Clin N Am. 2012 Feb;22(1):57-65, viii. doi: 10.1016/j.nic.2011.11.005. Epub 2011 Dec 6. Review.

PMID:
22284733
[PubMed - indexed for MEDLINE]
16.

Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B.

Johnson KA.

Curr Neurol Neurosci Rep. 2006 Nov;6(6):496-503. Review.

PMID:
17074285
[PubMed - indexed for MEDLINE]
17.

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation.

Klunk WE, Mathis CA.

Curr Opin Neurol. 2008 Dec;21(6):683-7. doi: 10.1097/WCO.0b013e3283168e1a. Review.

PMID:
18989113
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Impact of amyloid imaging on drug development in Alzheimer's disease.

Mathis CA, Lopresti BJ, Klunk WE.

Nucl Med Biol. 2007 Oct;34(7):809-22. Epub 2007 Sep 4. Review.

PMID:
17921032
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Mosconi L, McHugh PF.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):250-64. Review.

PMID:
21532539
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ.

J Alzheimers Dis. 2010;20(3):843-54. doi: 10.3233/JAD-2010-091504. Review.

PMID:
20182025
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk